This Solicitation opportunity from Department Of Defense was posted on June 7, 2026. The submission period has ended. Browse the details below for market research, or find similar active opportunities.
IOPAMIDOL INJECTION
Contract Overview
Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.
Active Opportunities Like This One
AI Contract Overview
The contract pertains to the procurement of Iopamidol Injection, identified by NSN/Part Number 6505-01-657-0664, with a total quantity requested of four units. This solicitation, numbered SPE2DP-26-T-3707, was posted on June 7, 2026, with a response deadline set for June 15, 2026. The contract is issued by the Defense Logistics Agency under the Department of Defense, indicating that the purchase is intended for federal use. No specific set-aside type or detailed NAICS code is provided, and the solicitation is classified as a general federal acquisition. The place of performance and detailed office address are unspecified, and no point of contact information is listed. The contract is primarily for the acquisition of the specified pharmaceutical product to support military or federal healthcare needs. Interested parties are directed to respond via the provided link to the Defense Logistics Agency's procurement portal.
General Info
Agency
NAICS
Place of Performance
USSet-Aside
Documents
(0)AI Contract Breakdown
Uniform Contract FormatNo contract breakdown available.
Cannot generate Contract Breakdown because no documents were found from this contract's source.
Timeline
Submission Closed
